Customer Q&A: Novartis

Novartis has a rich history of investing in the most promising frontiers of science, the most exciting innovations in the business of medicine, and the most significant healthcare needs. As the industry faces acute disruption, the company’s prescription for ongoing success hinges on APIs and microservices. Pascal Bouquet, Global Head of Architecture for Drug Development, answers a few questions about how digital transformation is moving Novartis forward.  

Previous Asset
Customer Q&A: Datlas
Customer Q&A: Datlas

Empowering enterprises to unlock the value of their data with API-driven business-process outsourcing

Next Asset
5 ways Erste Group is innovating with banking APIs
5 ways Erste Group is innovating with banking APIs

See how one of the largest banking institutions in Central and Eastern is aligning API technical implementa...